Waypoint Capital Advisors LLC Has $3.03 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Waypoint Capital Advisors LLC increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.5% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,181 shares of the healthcare conglomerate’s stock after buying an additional 78 shares during the quarter. Waypoint Capital Advisors LLC’s holdings in UnitedHealth Group were worth $3,029,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently bought and sold shares of the company. Kathleen S. Wright Associates Inc. purchased a new position in UnitedHealth Group in the third quarter valued at about $27,000. Macroview Investment Management LLC raised its position in UnitedHealth Group by 671.4% during the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after acquiring an additional 47 shares in the last quarter. Delos Wealth Advisors LLC grew its position in UnitedHealth Group by 757.1% in the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after acquiring an additional 53 shares in the last quarter. Bbjs Financial Advisors LLC bought a new position in shares of UnitedHealth Group during the 2nd quarter valued at $31,000. Finally, Global Wealth Strategies & Associates boosted its holdings in UnitedHealth Group by 152.4% in the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 32 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on UNH. TD Cowen upped their price target on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday. KeyCorp began coverage on UnitedHealth Group in a report on Friday, October 11th. They set an “overweight” rating and a $675.00 price target on the stock. Jefferies Financial Group raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and upped their price objective for the stock from $481.00 to $647.00 in a report on Wednesday, July 17th. Royal Bank of Canada cut their target price on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research report on Wednesday. Finally, Bank of America dropped their price objective on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday. Three research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average target price of $615.58.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $569.61 on Friday. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. The firm has a 50-day moving average price of $584.42 and a 200 day moving average price of $534.15. The firm has a market capitalization of $524.26 billion, a PE ratio of 34.82, a price-to-earnings-growth ratio of 1.69 and a beta of 0.58. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $608.63.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The business had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. During the same quarter in the previous year, the firm earned $6.56 EPS. UnitedHealth Group’s quarterly revenue was up 9.2% on a year-over-year basis. Research analysts anticipate that UnitedHealth Group Incorporated will post 27.68 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.47%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 51.34%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.